KROS – keros therapeutics, inc. - common stock (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

KROS

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/12

12:22 pm

kros

Keros Therapeutics (NASDAQ:KROS) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc.. They now have a $27.00 price target on the stock, up previously from $23.00.

Low Report

Keros Therapeutics (NASDAQ:KROS) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc.. They now have a $27.00 price target on the stock, up previously from $23.00.

Report

11/12

11:28 am

kros

Rating for KROS

Low Report

Rating for KROS

Report

11/12

11:28 am

kros

Rating for KROS

Low Report

Rating for KROS

Report

11/11

09:31 am

kros

Rating for KROS

Low Report

Rating for KROS

Report

11/11

09:31 am

kros

Rating for KROS

Low Report

Rating for KROS

Report

11/6

08:33 am

kros

Rating for KROS

Medium Report

Rating for KROS

Report

11/6

08:33 am

kros

Rating for KROS

Medium Report

Rating for KROS

Report

10/20

08:14 am

kros

Keros Therapeutics (NASDAQ:KROS) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $26.00 price target on the stock.

Medium Report

Keros Therapeutics (NASDAQ:KROS) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $26.00 price target on the stock.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.